Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2023-06.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89 Endocrinology and Metabolism
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism



Page Path
HOME > Endocrinol Metab > Volume 27(1); 2012 > Article
Case Report A Case of Sunitinib-Induced Destructive Thyroiditis.
Bu Kyung Kim, Young Sik Choi, Yo Han Park
Endocrinology and Metabolism 2012;27(1):68-71
DOI: https://doi.org/10.3803/EnM.2012.27.1.68
Published online: March 1, 2012
  • 23 Download
  • 0 Crossref
  • 0 Scopus
Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea. yschoi@kosinmed.or.kr

Sunitinib is a multi-targeted tyrosine-kinase inhibitor used for gastrointestinal stromal tumors and renal cell carcinoma (RCC). Several recent studies have reported sunitinib-induced hypothyroidism and thyroid dysfunction; however, the underlying mechanisms are not clear. Here, we report a patient with metastatic RCC, who developed destructive thyroidtis due to sunitinib treatment. The course followed in this case may be useful in understanding the clinical course of sunitinib-induced thyroiditis.

Related articles

Endocrinol Metab : Endocrinology and Metabolism